Rachel Saunders-Pullman, MD, MPH, MS
Associate Professor of Neurology at Albert Einstein College of Medicine
Attending Neurologist at Beth Israel Medical Center
Location: New York, New York, United States
Rachel Saunders-Pullman, MD, MPH, MS, is a clinical researcher whose focus is the study of genetic and epidemiologic factors relating to Parkinsonís disease (PD) and dystonia, especially the development of predictors and markers of PD. She is part of the LRRK2 Ashkenazi Jewish PD Consortium. She has been at Beth Israel Medical Center and Albert Einstein College of Medicine since 1998, where she is funded by The Michael J Fox Foundation, the NIH, the Marcled Foundation and the Empire Clinical Research Investigator Program. She is on the Scientific Advisory Board of the Dystonia Medical Research Foundation, the Executive Committee of the Dystonia Study Group and the Biomarkers Committee of the Parkinsonís Study Group.
After graduating summa cum laude from Amherst College, she received her medical and public health training at Columbia University College of Physicians and Surgeons. She was a resident and chief resident at the Neurological Institute at Columbia and completed movement disorder and neuroepidemiology fellowships at Columbia.
- Evaluation of glucocerebrosidase pathway biomarkers in Parkinson Disease (2016)
- Tumorigenesis in Parkinsonís Disease (2014)
- Gender differences in LRRK2 mutation and non-LRRK2 mutation PD, and expression of LRRK2 mutations (2013)
- LRRK2 Mutations and Cancer Risk (2012)
- Analytic Models in Biomarker Development (2011)
- Biomarker Battery Assessment in LRRK2 (2009)